English
简体中文
Total: £ 56.28
Published Date: 2025-05-06 | Pages: 87 | Tables: 85 | Medical Devices & Consumables
The global market for Implantable Neurostimulators was valued at US$ 5986 million in the year 2024 and is projected to reach a revised size of US$ 11700 million by 2031, growing at a CAGR of 10.2% during the forecast period.
Neurostimulation devices are implantable devices that help in the therapeutic activation of the nervous systems. These devices deliver electrical stimulation to the brain and nervous systems for the treatment of various types of neurological disorders such as pain, epilepsy, Parkinson's disease, depression, obsessive-compulsive disorder, dystonia, and tremors. These devices target specific areas of the brain or spinal cord by blocking the pain messages before they reach the brain.
The Implantable Neurostimulators market is primarily driven by the rising prevalence of neurological disorders such as Parkinson's disease, epilepsy, chronic pain, and depression. As the global population ages, the incidence of these chronic conditions is increasing, creating a growing demand for effective and long-term treatment options. Implantable neurostimulators offer a promising solution for managing symptoms of these conditions, particularly for patients who have not responded to conventional therapies. Technological advancements in neurostimulation devices, such as more refined targeting mechanisms, smaller device sizes, and enhanced patient control, are also fueling market growth by improving treatment outcomes and patient satisfaction.
However, the market faces several challenges, including the high cost of implantable devices and the associated surgical procedures. These costs can limit accessibility, especially in low- and middle-income countries or healthcare systems with budget constraints. Additionally, while neurostimulators have shown positive results in treating various conditions, concerns remain regarding the long-term effectiveness, potential side effects, and device-related complications, such as battery life and the need for device replacements. The complexity of implantation and post-operative care also presents challenges for healthcare providers, requiring specialized training and resources, which may hinder broader adoption.
North America is the largest sales region of implantable neurostimulation devices, with market share nearly 42% in 2023. Europe is the second largest sales of implantable neurostimulation devices, enjoying market share nearly 29% in 2023. Medtronic, Boston Scientific, Abbott, LivaNova are the leading company, with the market share about 90%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Implantable Neurostimulators, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Implantable Neurostimulators.
The Implantable Neurostimulators market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Implantable Neurostimulators market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Implantable Neurostimulators manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Medtronic
Boston Scientific
Abbott
LivaNova
Nevro
Ruishenan Medical
Beijing Pins
Sceneray
Inspire Medical Systems
Nurotron
Segment by Type
Deep Brain Stimulators
Spinal Cord Stimulators
Vagal Nerve Stimulators
Sacral Nerve Stimulators
Gastric Stimulators
Others
Segment by Application
Parkinson's Disease
Epilepsy
Pain
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Implantable Neurostimulators manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Implantable Neurostimulators in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Implantable Neurostimulators Market Overview
1.1 Product Definition
1.2 Implantable Neurostimulators by Type
1.2.1 Global Implantable Neurostimulators Market Value Comparison by Type (2024 VS 2031)
1.2.2 Deep Brain Stimulators
1.2.3 Spinal Cord Stimulators
1.2.4 Vagal Nerve Stimulators
1.2.5 Sacral Nerve Stimulators
1.2.6 Gastric Stimulators
1.2.7 Others
1.3 Implantable Neurostimulators by Application
1.3.1 Global Implantable Neurostimulators Market Value by Application (2024 VS 2031)
1.3.2 Parkinson's Disease
1.3.3 Epilepsy
1.3.4 Pain
1.3.5 Others
1.4 Global Implantable Neurostimulators Market Size Estimates and Forecasts
1.4.1 Global Implantable Neurostimulators Revenue 2020-2031
1.4.2 Global Implantable Neurostimulators Sales 2020-2031
1.4.3 Global Implantable Neurostimulators Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Implantable Neurostimulators Market Competition by Manufacturers
2.1 Global Implantable Neurostimulators Sales Market Share by Manufacturers (2020-2025)
2.2 Global Implantable Neurostimulators Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Implantable Neurostimulators Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Implantable Neurostimulators, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Implantable Neurostimulators, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Implantable Neurostimulators, Product Type & Application
2.7 Global Key Manufacturers of Implantable Neurostimulators, Date of Enter into This Industry
2.8 Global Implantable Neurostimulators Market Competitive Situation and Trends
2.8.1 Global Implantable Neurostimulators Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Implantable Neurostimulators Players Market Share by Revenue
2.8.3 Global Implantable Neurostimulators Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Implantable Neurostimulators Market Scenario by Region
3.1 Global Implantable Neurostimulators Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Implantable Neurostimulators Sales by Region: 2020-2031
3.2.1 Global Implantable Neurostimulators Sales by Region: 2020-2025
3.2.2 Global Implantable Neurostimulators Sales by Region: 2026-2031
3.3 Global Implantable Neurostimulators Revenue by Region: 2020-2031
3.3.1 Global Implantable Neurostimulators Revenue by Region: 2020-2025
3.3.2 Global Implantable Neurostimulators Revenue by Region: 2026-2031
3.4 North America Implantable Neurostimulators Market Facts & Figures by Country
3.4.1 North America Implantable Neurostimulators Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Implantable Neurostimulators Sales by Country (2020-2031)
3.4.3 North America Implantable Neurostimulators Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Implantable Neurostimulators Market Facts & Figures by Country
3.5.1 Europe Implantable Neurostimulators Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Implantable Neurostimulators Sales by Country (2020-2031)
3.5.3 Europe Implantable Neurostimulators Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Implantable Neurostimulators Market Facts & Figures by Region
3.6.1 Asia Pacific Implantable Neurostimulators Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Implantable Neurostimulators Sales by Region (2020-2031)
3.6.3 Asia Pacific Implantable Neurostimulators Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Implantable Neurostimulators Market Facts & Figures by Country
3.7.1 Latin America Implantable Neurostimulators Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Implantable Neurostimulators Sales by Country (2020-2031)
3.7.3 Latin America Implantable Neurostimulators Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Implantable Neurostimulators Market Facts & Figures by Country
3.8.1 Middle East and Africa Implantable Neurostimulators Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Implantable Neurostimulators Sales by Country (2020-2031)
3.8.3 Middle East and Africa Implantable Neurostimulators Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Implantable Neurostimulators Sales by Type (2020-2031)
4.1.1 Global Implantable Neurostimulators Sales by Type (2020-2025)
4.1.2 Global Implantable Neurostimulators Sales by Type (2026-2031)
4.1.3 Global Implantable Neurostimulators Sales Market Share by Type (2020-2031)
4.2 Global Implantable Neurostimulators Revenue by Type (2020-2031)
4.2.1 Global Implantable Neurostimulators Revenue by Type (2020-2025)
4.2.2 Global Implantable Neurostimulators Revenue by Type (2026-2031)
4.2.3 Global Implantable Neurostimulators Revenue Market Share by Type (2020-2031)
4.3 Global Implantable Neurostimulators Price by Type (2020-2031)
5 Segment by Application
5.1 Global Implantable Neurostimulators Sales by Application (2020-2031)
5.1.1 Global Implantable Neurostimulators Sales by Application (2020-2025)
5.1.2 Global Implantable Neurostimulators Sales by Application (2026-2031)
5.1.3 Global Implantable Neurostimulators Sales Market Share by Application (2020-2031)
5.2 Global Implantable Neurostimulators Revenue by Application (2020-2031)
5.2.1 Global Implantable Neurostimulators Revenue by Application (2020-2025)
5.2.2 Global Implantable Neurostimulators Revenue by Application (2026-2031)
5.2.3 Global Implantable Neurostimulators Revenue Market Share by Application (2020-2031)
5.3 Global Implantable Neurostimulators Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Company Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Implantable Neurostimulators Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Medtronic Implantable Neurostimulators Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Boston Scientific
6.2.1 Boston Scientific Company Information
6.2.2 Boston Scientific Description and Business Overview
6.2.3 Boston Scientific Implantable Neurostimulators Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Boston Scientific Implantable Neurostimulators Product Portfolio
6.2.5 Boston Scientific Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Company Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Implantable Neurostimulators Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Abbott Implantable Neurostimulators Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 LivaNova
6.4.1 LivaNova Company Information
6.4.2 LivaNova Description and Business Overview
6.4.3 LivaNova Implantable Neurostimulators Sales, Revenue and Gross Margin (2020-2025)
6.4.4 LivaNova Implantable Neurostimulators Product Portfolio
6.4.5 LivaNova Recent Developments/Updates
6.5 Nevro
6.5.1 Nevro Company Information
6.5.2 Nevro Description and Business Overview
6.5.3 Nevro Implantable Neurostimulators Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Nevro Implantable Neurostimulators Product Portfolio
6.5.5 Nevro Recent Developments/Updates
6.6 Ruishenan Medical
6.6.1 Ruishenan Medical Company Information
6.6.2 Ruishenan Medical Description and Business Overview
6.6.3 Ruishenan Medical Implantable Neurostimulators Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Ruishenan Medical Implantable Neurostimulators Product Portfolio
6.6.5 Ruishenan Medical Recent Developments/Updates
6.7 Beijing Pins
6.7.1 Beijing Pins Company Information
6.7.2 Beijing Pins Description and Business Overview
6.7.3 Beijing Pins Implantable Neurostimulators Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Beijing Pins Implantable Neurostimulators Product Portfolio
6.7.5 Beijing Pins Recent Developments/Updates
6.8 Sceneray
6.8.1 Sceneray Company Information
6.8.2 Sceneray Description and Business Overview
6.8.3 Sceneray Implantable Neurostimulators Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sceneray Implantable Neurostimulators Product Portfolio
6.8.5 Sceneray Recent Developments/Updates
6.9 Inspire Medical Systems
6.9.1 Inspire Medical Systems Company Information
6.9.2 Inspire Medical Systems Description and Business Overview
6.9.3 Inspire Medical Systems Implantable Neurostimulators Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Inspire Medical Systems Implantable Neurostimulators Product Portfolio
6.9.5 Inspire Medical Systems Recent Developments/Updates
6.10 Nurotron
6.10.1 Nurotron Company Information
6.10.2 Nurotron Description and Business Overview
6.10.3 Nurotron Implantable Neurostimulators Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Nurotron Implantable Neurostimulators Product Portfolio
6.10.5 Nurotron Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Implantable Neurostimulators Industry Chain Analysis
7.2 Implantable Neurostimulators Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Implantable Neurostimulators Production Mode & Process Analysis
7.4 Implantable Neurostimulators Sales and Marketing
7.4.1 Implantable Neurostimulators Sales Channels
7.4.2 Implantable Neurostimulators Distributors
7.5 Implantable Neurostimulators Customer Analysis
8 Implantable Neurostimulators Market Dynamics
8.1 Implantable Neurostimulators Industry Trends
8.2 Implantable Neurostimulators Market Drivers
8.3 Implantable Neurostimulators Market Challenges
8.4 Implantable Neurostimulators Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Implantable Neurostimulators Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Implantable Neurostimulators Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Implantable Neurostimulators Market Competitive Situation by Manufacturers in 2024
Table 4. Global Implantable Neurostimulators Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Implantable Neurostimulators Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Implantable Neurostimulators Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Implantable Neurostimulators Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Implantable Neurostimulators Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Implantable Neurostimulators, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Implantable Neurostimulators, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Implantable Neurostimulators, Product Type & Application
Table 12. Global Key Manufacturers of Implantable Neurostimulators, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Implantable Neurostimulators by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Implantable Neurostimulators as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Implantable Neurostimulators Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Implantable Neurostimulators Sales by Region (2020-2025) & (K Units)
Table 18. Global Implantable Neurostimulators Sales Market Share by Region (2020-2025)
Table 19. Global Implantable Neurostimulators Sales by Region (2026-2031) & (K Units)
Table 20. Global Implantable Neurostimulators Sales Market Share by Region (2026-2031)
Table 21. Global Implantable Neurostimulators Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Implantable Neurostimulators Revenue Market Share by Region (2020-2025)
Table 23. Global Implantable Neurostimulators Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Implantable Neurostimulators Revenue Market Share by Region (2026-2031)
Table 25. North America Implantable Neurostimulators Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Implantable Neurostimulators Sales by Country (2020-2025) & (K Units)
Table 27. North America Implantable Neurostimulators Sales by Country (2026-2031) & (K Units)
Table 28. North America Implantable Neurostimulators Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Implantable Neurostimulators Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Implantable Neurostimulators Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Implantable Neurostimulators Sales by Country (2020-2025) & (K Units)
Table 32. Europe Implantable Neurostimulators Sales by Country (2026-2031) & (K Units)
Table 33. Europe Implantable Neurostimulators Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Implantable Neurostimulators Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Implantable Neurostimulators Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Implantable Neurostimulators Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Implantable Neurostimulators Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Implantable Neurostimulators Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Implantable Neurostimulators Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Implantable Neurostimulators Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Implantable Neurostimulators Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Implantable Neurostimulators Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Implantable Neurostimulators Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Implantable Neurostimulators Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Implantable Neurostimulators Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Implantable Neurostimulators Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Implantable Neurostimulators Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Implantable Neurostimulators Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Implantable Neurostimulators Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Implantable Neurostimulators Sales (K Units) by Type (2020-2025)
Table 51. Global Implantable Neurostimulators Sales (K Units) by Type (2026-2031)
Table 52. Global Implantable Neurostimulators Sales Market Share by Type (2020-2025)
Table 53. Global Implantable Neurostimulators Sales Market Share by Type (2026-2031)
Table 54. Global Implantable Neurostimulators Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Implantable Neurostimulators Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Implantable Neurostimulators Revenue Market Share by Type (2020-2025)
Table 57. Global Implantable Neurostimulators Revenue Market Share by Type (2026-2031)
Table 58. Global Implantable Neurostimulators Price (USD/Unit) by Type (2020-2025)
Table 59. Global Implantable Neurostimulators Price (USD/Unit) by Type (2026-2031)
Table 60. Global Implantable Neurostimulators Sales (K Units) by Application (2020-2025)
Table 61. Global Implantable Neurostimulators Sales (K Units) by Application (2026-2031)
Table 62. Global Implantable Neurostimulators Sales Market Share by Application (2020-2025)
Table 63. Global Implantable Neurostimulators Sales Market Share by Application (2026-2031)
Table 64. Global Implantable Neurostimulators Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Implantable Neurostimulators Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Implantable Neurostimulators Revenue Market Share by Application (2020-2025)
Table 67. Global Implantable Neurostimulators Revenue Market Share by Application (2026-2031)
Table 68. Global Implantable Neurostimulators Price (USD/Unit) by Application (2020-2025)
Table 69. Global Implantable Neurostimulators Price (USD/Unit) by Application (2026-2031)
Table 70. Medtronic Company Information
Table 71. Medtronic Description and Business Overview
Table 72. Medtronic Implantable Neurostimulators Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Medtronic Implantable Neurostimulators Product
Table 74. Medtronic Recent Developments/Updates
Table 75. Boston Scientific Company Information
Table 76. Boston Scientific Description and Business Overview
Table 77. Boston Scientific Implantable Neurostimulators Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Boston Scientific Implantable Neurostimulators Product
Table 79. Boston Scientific Recent Developments/Updates
Table 80. Abbott Company Information
Table 81. Abbott Description and Business Overview
Table 82. Abbott Implantable Neurostimulators Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Abbott Implantable Neurostimulators Product
Table 84. Abbott Recent Developments/Updates
Table 85. LivaNova Company Information
Table 86. LivaNova Description and Business Overview
Table 87. LivaNova Implantable Neurostimulators Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. LivaNova Implantable Neurostimulators Product
Table 89. LivaNova Recent Developments/Updates
Table 90. Nevro Company Information
Table 91. Nevro Description and Business Overview
Table 92. Nevro Implantable Neurostimulators Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Nevro Implantable Neurostimulators Product
Table 94. Nevro Recent Developments/Updates
Table 95. Ruishenan Medical Company Information
Table 96. Ruishenan Medical Description and Business Overview
Table 97. Ruishenan Medical Implantable Neurostimulators Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Ruishenan Medical Implantable Neurostimulators Product
Table 99. Ruishenan Medical Recent Developments/Updates
Table 100. Beijing Pins Company Information
Table 101. Beijing Pins Description and Business Overview
Table 102. Beijing Pins Implantable Neurostimulators Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Beijing Pins Implantable Neurostimulators Product
Table 104. Beijing Pins Recent Developments/Updates
Table 105. Sceneray Company Information
Table 106. Sceneray Description and Business Overview
Table 107. Sceneray Implantable Neurostimulators Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Sceneray Implantable Neurostimulators Product
Table 109. Sceneray Recent Developments/Updates
Table 110. Inspire Medical Systems Company Information
Table 111. Inspire Medical Systems Description and Business Overview
Table 112. Inspire Medical Systems Implantable Neurostimulators Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Inspire Medical Systems Implantable Neurostimulators Product
Table 114. Inspire Medical Systems Recent Developments/Updates
Table 115. Nurotron Company Information
Table 116. Nurotron Description and Business Overview
Table 117. Nurotron Implantable Neurostimulators Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Nurotron Implantable Neurostimulators Product
Table 119. Nurotron Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Implantable Neurostimulators Distributors List
Table 123. Implantable Neurostimulators Customers List
Table 124. Implantable Neurostimulators Market Trends
Table 125. Implantable Neurostimulators Market Drivers
Table 126. Implantable Neurostimulators Market Challenges
Table 127. Implantable Neurostimulators Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Implantable Neurostimulators
Figure 2. Global Implantable Neurostimulators Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Implantable Neurostimulators Market Share by Type: 2024 & 2031
Figure 4. Deep Brain Stimulators Product Picture
Figure 5. Spinal Cord Stimulators Product Picture
Figure 6. Vagal Nerve Stimulators Product Picture
Figure 7. Sacral Nerve Stimulators Product Picture
Figure 8. Gastric Stimulators Product Picture
Figure 9. Others Product Picture
Figure 10. Global Implantable Neurostimulators Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global Implantable Neurostimulators Market Share by Application: 2024 & 2031
Figure 12. Parkinson's Disease
Figure 13. Epilepsy
Figure 14. Pain
Figure 15. Others
Figure 16. Global Implantable Neurostimulators Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Implantable Neurostimulators Market Size (2020-2031) & (US$ Million)
Figure 18. Global Implantable Neurostimulators Sales (2020-2031) & (K Units)
Figure 19. Global Implantable Neurostimulators Average Price (USD/Unit) & (2020-2031)
Figure 20. Implantable Neurostimulators Report Years Considered
Figure 21. Implantable Neurostimulators Sales Share by Manufacturers in 2024
Figure 22. Global Implantable Neurostimulators Revenue Share by Manufacturers in 2024
Figure 23. Global 5 and 10 Largest Implantable Neurostimulators Players: Market Share by Revenue in Implantable Neurostimulators in 2024
Figure 24. Implantable Neurostimulators Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Global Implantable Neurostimulators Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 26. North America Implantable Neurostimulators Sales Market Share by Country (2020-2031)
Figure 27. North America Implantable Neurostimulators Revenue Market Share by Country (2020-2031)
Figure 28. U.S. Implantable Neurostimulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Canada Implantable Neurostimulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Europe Implantable Neurostimulators Sales Market Share by Country (2020-2031)
Figure 31. Europe Implantable Neurostimulators Revenue Market Share by Country (2020-2031)
Figure 32. Germany Implantable Neurostimulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. France Implantable Neurostimulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. U.K. Implantable Neurostimulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Italy Implantable Neurostimulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Russia Implantable Neurostimulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Asia Pacific Implantable Neurostimulators Sales Market Share by Region (2020-2031)
Figure 38. Asia Pacific Implantable Neurostimulators Revenue Market Share by Region (2020-2031)
Figure 39. China Implantable Neurostimulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Japan Implantable Neurostimulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. South Korea Implantable Neurostimulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. India Implantable Neurostimulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Australia Implantable Neurostimulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. China Taiwan Implantable Neurostimulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Indonesia Implantable Neurostimulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Thailand Implantable Neurostimulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Malaysia Implantable Neurostimulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Latin America Implantable Neurostimulators Sales Market Share by Country (2020-2031)
Figure 49. Latin America Implantable Neurostimulators Revenue Market Share by Country (2020-2031)
Figure 50. Mexico Implantable Neurostimulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Brazil Implantable Neurostimulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Argentina Implantable Neurostimulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Middle East and Africa Implantable Neurostimulators Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Implantable Neurostimulators Revenue Market Share by Country (2020-2031)
Figure 55. Turkey Implantable Neurostimulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Implantable Neurostimulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. UAE Implantable Neurostimulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Global Sales Market Share of Implantable Neurostimulators by Type (2020-2031)
Figure 59. Global Revenue Market Share of Implantable Neurostimulators by Type (2020-2031)
Figure 60. Global Implantable Neurostimulators Price (USD/Unit) by Type (2020-2031)
Figure 61. Global Sales Market Share of Implantable Neurostimulators by Application (2020-2031)
Figure 62. Global Revenue Market Share of Implantable Neurostimulators by Application (2020-2031)
Figure 63. Global Implantable Neurostimulators Price (USD/Unit) by Application (2020-2031)
Figure 64. Implantable Neurostimulators Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
